Specialty Diagnostics

Esco Aster specialty diagnostics division provides a variety of products which are used as active ingredients/reagents to form final kit to upcoming small-scale test kits.

We enable linearly scalable contract development and manufacturing of up to 1,200 /hr.

Such kits include:

  • Lateral Flow Immunoassays (LFIA)
  • Enzyme-linked Immunosorbent Assays (ELISA)
  • Chemiluminescent Immunoassays (CLIA)

We are providing oligonucleotide-based, antigen-antibody reagents as well as PCR enzymes for our collaborators and clients. We use fermentation and mammalian cell line expression in adherent / suspension culture for the following applications:

  • Real-time quantitative Polymerase Chain Reaction (RT-qPCR)
  • Direct Polymerase Chain Reaction--without extraction
  • Loop-mediated Isothermal Amplification (LAMP) / Isothermal Polymerase Chain Reaction)

Our Internal Pipeline

Our internal pipeline consists of best-in-class complementary diagnostics that can be paired with our bio-vaccine-cell and gene therapy manufacturing.

RCL Diagnostics for IPQC and Post Administration of CAR-T
In Vivo Cancer Imaging Diagnostics / Theranostics
Exosome Markers RT-PCR for Stem Cell Therapy
RT-PCR /qPCR AAV Gene Therapy, LV/RV Gene-edited Cell Therapy (transfer of E1A / SV40 / VSVG, viral genome titer, residual host cell DNA, residual plasmid DNA, viral stability-qPCR)
CLIA for COVID-19 Vaccine

We are constantly looking for new modality patented diagnostics that are class III de novo, best-in-class to exclusively inward license and commercialize to supplement our best-in-class manufacturing platforms.

These are then sold directly by us in ASEAN/ANZ, HK and Taiwan, sub-licensed in rest of world. These may be sold with our Aster Xpress ™ diagnostic laboratory globally as laboratory-developed tests (LDTs) or as standalone diagnostic laboratory.



Some services are still being built up and ready only by Y2024. Please inquire for further information and updates through